Evidence map›Paper›PMID 34681039›Full record

ReviewGenes2021

Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development.

Mark C Wilkes, Aya Shibuya, Kathleen M Sakamoto

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mark C WilkesDivision of Hematology/Oncology, Department of Pediatrics, Lucile Packard Children's Hospital at Stanford University, Palo Alto, CA 94305, USA.
Aya ShibuyaDivision of Hematology/Oncology, Department of Pediatrics, Lucile Packard Children's Hospital at Stanford University, Palo Alto, CA 94305, USA.
Kathleen M SakamotoDivision of Hematology/Oncology, Department of Pediatrics, Lucile Packard Children's Hospital at Stanford University, Palo Alto, CA 94305, USA.
Lucile Packard Children's Hospital · USStanford University · US

Funding

Training in Pediatric Nonmalignant Hematology and Stem Cell BiologyT32DK098132 · NIDDK · STANFORD UNIVERSITY · PI SAKAMOTO, KATHLEEN M · 2014 to 2022
$1.9M
The Role of Intrinsic and Extrinsic Factors in Megakaryocytic-Erythroid Progenitor Lineage CommitmentK01DK120798 · NIDDK · YALE UNIVERSITY · PI SCANLON, VANESSA M. · 2019 to 2023
$931k
Characterization of the Role of Nemo-like Kinase in Normal and Diamond Blackfan Anemia Models of Erythropoiesis.K01DK123140 · NIDDK · STANFORD UNIVERSITY · PI WILKES, MARK CHRISTOPHER · 2021 to 2025
$763k
NIDDK NIH HHS K01 DK123140NIDDK NIH HHS T32 DK098132
6 · The paper itself

Abstract

Blood cell development is regulated through intrinsic gene regulation and local factors including the microenvironment and cytokines. The differentiation of hematopoietic stem and progenitor cells (HSPCs) into mature erythrocytes is dependent on these cytokines binding to and stimulating their cognate receptors and the signaling cascades they initiate. Many of these pathways include kinases that can diversify signals by phosphorylating multiple substrates and amplify signals by phosphorylating multiple copies of each substrate. Indeed, synthesis of many of these cytokines is regulated by a number of signaling pathways including phosphoinositide 3-kinase (PI3K)-, extracellular signal related kinases (ERK)-, and p38 kinase-dependent pathways. Therefore, kinases act both upstream and downstream of the erythropoiesis-regulating cytokines. While many of the cytokines are well characterized, the nuanced members of the network of kinases responsible for appropriate induction of, and response to, these cytokines remains poorly defined. Here, we will examine the kinase signaling cascades required for erythropoiesis and emphasize the importance, complexity, enormous amount remaining to be characterized, and therapeutic potential that will accompany our comprehensive understanding of the erythroid kinome in both healthy and diseased states.

Indexed as

Cell DifferentiationErythrocytesErythropoiesisExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHumansMAP Kinase Signaling SystemPhosphatidylinositol 3-KinasesPhosphorylationExtracellular Signal-Regulated MAP KinasesPhosphatidylinositol 3-Kinasescell signalingerythropoiesiskinases

Identifiers

PMID34681039
PMCPMC8536016
OpenAlexW3206902494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.